Entry Detail


General Information

Database ID:exR0726310
RNA Name:ABHD12
RNA Type:mRNA
Chromosome:chr20
Starnd:-
Coordinate:
Start Site(bp):25294742End Site(bp):25390835
External Links:ENSG00000100997



Disease Information

Disease Name:Bladder Cancer
Disease Category:Cancers
MeSH ID:D001749
Type:Neoplasms/Urogenital Neoplasms
Alias:Urinary Bladder Neoplasms//Neoplasm, Urinary Bladder//Urinary Bladder Neoplasm//Neoplasms, Bladder//Bladder Neoplasms//Bladder Neoplasm//Neoplasm, Bladder//Bladder Tumors//Bladder Tumor//Tumor, Bladder//Tumors, Bladder//Urinary Bladder Cancer//Cancer, Urinary Bladder//Malignant Tumor of Urinary Bladder//Cancer of the Bladder//Bladder Cancer//Bladder Cancers//Cancer, Bladder//Cancer of Bladder



Expression Detail

GEO ID:GSE51843
Description:A Pilot Study on the Potential of RNA-Associated to Urinary Vesicles as a Suitable Non-Invasive Source for Diagnostic Purposes in Bladder Cancer
Experimental Design:Cancer vs Control
Case Disease Type:Bladder Cancer
Case Disease SubType:NA
Case Sample:Bladder Cancer
Control Sample:Control
Number of Case:5
Number of Control:6
Number of Samples:11





Regulatory Relationship

mRNA targets:
Gene SymbolChromosomeStart Site(bp)End Site(bp)Strand
NAT8L
chr4
2059327
2069089
+
MAN2A1
chr5
109689366
109869625
+
CUTC
chr10
99702558
99756134
+
ERAL1
chr17
28855010
28861061
+
HMOX1
chr22
35380361
35394207
+
MSL2
chr3
136148917
136197241
-
ERBB2
chr17
39687914
39730426
+
RPL8
chr8
144789765
144792587
-
MX1
chr21
41420304
41459214
+
ACP6
chr1
147629652
147670524
-
SIRT6
chr19
4174109
4182566
-
LSM7
chr19
2321520
2328611
-
PDCD2L
chr19
34404399
34426168
+
TPX2
chr20
31739271
31801805
+
ZNF764
chr16
30553764
30558498
-
TSPAN3
chr15
77041404
77083984
-
CXADR
chr21
17513043
17593579
+
ARIH2
chr3
48918821
48986382
+
RBM27
chr5
146203605
146289223
+
GINS1
chr20
25407673
25452628
+
UBE2J1
chr6
89326625
89352722
-
RBM22
chr5
150690792
150701077
-
EEF2
chr19
3976056
3985463
-
MED16
chr19
867630
893218
-
CYB5R3
chr22
42617840
42649392
-
PHIP
chr6
78934419
79078254
-
RBFA
chr18
80034389
80050651
+
EIF2S2
chr20
34088309
34112243
-
FKBP10
chr17
41812680
41823213
+
EML4
chr2
42169353
42332548
+
miRNA targets:NA
circRNA targets:NA
lncRNA targets:
lncRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
AC012236.1
chr15
31221999
31230838
-
AD000090.1
chr19
35557956
35581954
+
AL135925.1
chr10
79825902
79827602
+
SNHG22
chr18
49814023
49851059
+
XIST
chrX
73820649
73852723
-
Display:



Experiment Detail

GEO ID:NA
Sample Source:NA
Source Fraction:NA
Platform:NA
Method:NA
Num of detected RNA Type:NA
Num of detected RNAs of this Type:NA
Sample treatment protocol:NA
RNA Extract protocol:NA
RNA library preparation protocol:NA



Reference

PMID:24458310
Title:A Pilot Study on the Potential of RNA-Associated to Urinary Vesicles as a Suitable Non-Invasive Source for Diagnostic Purposes in Bladder Cancer.
Author:Perez A, Loizaga A, Arceo R, Lacasa I, Rabade A, Zorroza K,Mosen-Ansorena D, Gonzalez E, Aransay AM, Falcon-Perez JM, Unda-Urzaiz M, Royo F.
Journal:Cancers (Basel). 2014 Jan 22;6(1):179-92.
Description:LASS2 and GALNT1 were present in cancer patients, while ARHGEF39 and FOXO3 were found only in non-cancer urinary vesicles, which could be diagnostic markers for bladder cancer.